Will GLP-1s Be the Downfall of the Food Industry?
Will GLP-1 drugs like Ozempic and Wegovy spell the downfall of the food industry -- or at the very least the snack food industry? In this episode, we look at the hype around GLP-1 drugs and try to uncover the real learnings for restaurants and food manufacturers. From food noise to portion sizes to what consumers consider to be healthy today, registered dietitian nutritionist and industry expert Pam Smith (a co-creator of the Seasons 52 brand, which created the original mini dessert portion trend) has a messy conversation with Maeve and Mike. Plus, we look at the controversy around Michelin-starred Eleven Madison Park adding meat back to the menu. And, as always, we end with the Mess Hall Five Questions, where Pam Smith shares her opinion on whether a hot dog is a sandwich.
